Contact
Please use this form to send email to PR contact of this press release:
Enamine's IDD Platform Accelerates Nuclide Therapeutics' Precision Radiotheranostics Pipeline Towards the Clinic
TO:
Oleksii Gavrylenko
Enamine Ltd